Literature DB >> 25304609

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies.

Benjamin W Teh1, Jasmine C Teng2, Karin Urbancic3, Andrew Grigg4, Simon J Harrison5, Leon J Worth6, Monica A Slavin7, Karin A Thursky7.   

Abstract

Entities:  

Keywords:  fungal infection; myeloma; novel agents

Mesh：

Substances：

Year:  2014        PMID： 25304609      PMCID： PMC4281332          DOI： 10.3324/haematol.2014.114025

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.

Authors:  L Gil; M Kozlowska-Skrzypczak; A Mol; D Poplawski; J Styczynski; M Komarnicki
Journal:  Bone Marrow Transplant       Date:  2008-09-15       Impact factor: 5.483

2.  Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy.

Authors:  M A Slavin; C H Heath; K A Thursky; C O Morrissey; J Szer; L M Ling; S T Milliken; A P Grigg
Journal:  Intern Med J       Date:  2008-06       Impact factor: 2.048

3.  Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.

Authors:  O Lortholary; S Ascioglu; P Moreau; R Herbrecht; A Marinus; P Casassus; B De Pauw; D W Denning
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

4.  Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.

Authors:  S Vincent Rajkumar; Jean-Luc Harousseau; Brian Durie; Kenneth C Anderson; Meletios Dimopoulos; Robert Kyle; Joan Blade; Paul Richardson; Robert Orlowski; David Siegel; Sundar Jagannath; Thierry Facon; Hervé Avet-Loiseau; Sagar Lonial; Antonio Palumbo; Jeffrey Zonder; Heinz Ludwig; David Vesole; Orhan Sezer; Nikhil C Munshi; Jesus San Miguel
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

5.  Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic.

Authors:  Ingemar Turesson; Ramon Velez; Sigurdur Y Kristinsson; Ola Landgren
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

Review 6.  Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection.

Authors:  Benjamin W Teh; Simon J Harrison; Marc Pellegrini; Karin A Thursky; Leon J Worth; Monica A Slavin
Journal:  Blood Rev       Date:  2014-02-10       Impact factor: 8.250

Review 7.  Immunomodulatory drugs in multiple myeloma.

Authors:  Swati Andhavarapu; Vivek Roy
Journal:  Expert Rev Hematol       Date:  2013-02       Impact factor: 2.929

8.  Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.

Authors:  E Jantunen; J Salonen; E Juvonen; E Koivunen; T Siitonen; T Lehtinen; O Kuittinen; S Leppä; V-J Anttila; M Itälä; T Wiklund; K Remes; T Nousiainen
Journal:  Eur J Haematol       Date:  2004-09       Impact factor: 2.997

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area.

Authors:  M Cornet; L Fleury; C Maslo; J-F Bernard; G Brücker
Journal:  J Hosp Infect       Date:  2002-08       Impact factor: 3.926
View more
  16 in total

1.  FDG PET/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging.

Authors:  A P Douglas; K A Thursky; L J Worth; E Drummond; A Hogg; R J Hicks; M A Slavin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-07       Impact factor: 9.236

2.  Epidemiology of invasive fungal disease in lymphoproliferative disorders.

Authors:  Jasmine C Teng; Monica A Slavin; Benjamin W Teh; Senthil M Lingaratnam; Michelle R Ananda-Rajah; Leon J Worth; John F Seymour; Karin A Thursky
Journal:  Haematologica       Date:  2015-07-23       Impact factor: 9.941

3.  Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study.

Authors:  Maria Chiara Tisi; Stefan Hohaus; Annarosa Cuccaro; Idanna Innocenti; Elena De Carolis; Tommaso Za; Francesco D'Alò; Luca Laurenti; Luana Fianchi; Simona Sica; Maurizio Sanguinetti; Valerio De Stefano; Livio Pagano
Journal:  Haematologica       Date:  2016-11-17       Impact factor: 9.941

Review 4.  ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).

Authors:  G Redelman-Sidi; O Michielin; C Cervera; C Ribi; J M Aguado; M Fernández-Ruiz; O Manuel
Journal:  Clin Microbiol Infect       Date:  2018-02-07       Impact factor: 8.067

5.  Clinical Outcomes in Multiple Myeloma Post-Autologous Transplantation-A Single Centre Experience.

Authors:  Uday Kulkarni; Anup J Devasia; Anu Korula; N A Fouzia; P N Nisham; Yasir J Samoon; Kavitha M Lakshmi; Aby Abraham; Alok Srivastava; Vikram Mathews; Biju George
Journal:  Indian J Hematol Blood Transfus       Date:  2018-07-21       Impact factor: 0.900

Review 6.  Clinical Considerations for Immunoparesis in Multiple Myeloma.

Authors:  Michael Chahin; Zachery Branham; Ashley Fox; Christian Leurinda; Amany R Keruakous
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

7.  Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.

Authors:  Junru Liu; He Huang; Yan Li; Lin Liu; Jianyong Li; Zhuogang Liu; Jin Lu; Jian Ouyang; Yongping Song; Daobin Zhou; Hanyun Ren; Jun Ma; Chun Wang; Li Yu; Jin Zhou; Jianmin Wang; Yang Xiao; Xiaojun Huang; Juan Li
Journal:  Tumour Biol       Date:  2015-12-23

8.  Aspergillus and Rhizopus Fungal Coinfection in a Patient With Multiple Myeloma.

Authors:  Anum Aqsa; Sami Droubi; Allison Glaser
Journal:  Cureus       Date:  2020-05-11

9.  Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens.

Authors:  Shin Young Hyun; Sang Hoon Han; Soo-Jeong Kim; Ji Eun Jang; Yundeok Kim; Hyunsoo Cho; Jung Yeon Lee; June-Won Cheong; Yoo Hong Min; Jae-Woo Song; Jin Seok Kim
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

10.  Secondary Immunodeficiency and Hypogammaglobulinemia with IgG Levels of <5 g/L in Patients with Multiple Myeloma: A Retrospective Study Between 2012 and 2020 at a University Hospital in China.

Authors:  Chunmei Ye; Weiwei Chen; Qi Gao; Yanxia Chen; Xiaolu Song; Sujie Zheng; Jinlin Liu
Journal:  Med Sci Monit       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.